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Abstract
Here we report the derivation and characteriza-
tion of new human embryonic stem cell (hESC) lines, 
SNUhES1, SNUhES2, and SNUhES3. These cells, 
established from the inner cell mass using an STO 
feeder layer, satisfy the criteria that characterize plu-
ripotent hESCs: The cell lines express high levels of 
alkaline phosphatase, cell surface markers (such as 
SSEA-3, SSEA-4, TRA-1-60, and TRA-1-81), tran-
scription factor Oct-4, and telomerase. When grafted 
into severe combined immunodeficient mice after 
prolonged proliferation, these cells maintained the 
developmental potentials to form derivatives of all 
three embryonic germ layers. The cell lines have nor-
mal karyotypes and distinct identities, revealed from 
DNA fingerprinting. Interestingly, analysis by elec-
tron microscopy clearly shows the morphological dif-
ference between undifferentiated and differentiated 
hESCs. Undifferentiated hESCs have a high ratio of 
nucleus to cytoplasm, prominent nucleoli, indistinct 
cell membranes, free ribosomes, and small mitochon-
dria with a few crista, whereas differentiated cells 
retain irregular nuclear morphology, desmosomes, 
extensive cytoplasmic membranes, tonofilaments, and 
highly developed cellular organelles such as Golgi com-
plex with secretory vesicles, endoplasmic reticulum 
studded with ribosomes, and large mitochondria. Exis-
tence of desmosomes and tonofilaments indicates that 
these cells differentiated into epithelial cells. When in 
vitro differentiation potentials of these cell lines into 
cardiomyocytes were examined, SNUhES3 was found 
to differentiate into cardiomyocytes most effectively. 
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Introduction
Since mouse embryonic stem cells (mESCs) were isolated 
and cultured in vitro two decades ago [1, 2], the research of 
ESCs has made outstanding contributions to our understand-
ing of developmental biology. ESCs, derived from the inner 
cell mass (ICM) in preimplantation embryos, can proliferate 
extensively in vitro while maintaining an undifferentiated 
state and differentiate into most cell types under certain con-
ditions [3–8]. This ability of ESCs makes them a good source 
for cell replacement therapy [9]. In addition, ESCs can be used 
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as a source for study of basic developmental biology, iden-
tification of factors that are involved in regulation of devel-
opmental processes and differentiation into certain cells or 
tissue, and screening for drugs or toxins [4].
Human ESC (hESC) lines have been successfully 
derived from human blastocysts [10–13]. Derivation and 
characterization of hESCs is very important in terms of 
the direct application to human diseases. Like mESCs, the 
essential characteristics of hESCs include (a) derivation 
from the preimplantation embryos, (b) prolonged prolif-
eration in vitro, and (c) stable developmental potentials to 
form derivatives of all three embryonic germ layers even 
after prolonged culture. However, hESCs are different 
from mESCs in the expression of markers. Stage-specific 
embryonic antigen-1 (SSEA-1), a cell surface marker, is 
expressed in mESCs but not in hESCs [10–13]. In contrast, 
SSEA-3, SSEA-4, TRA-1-60, and TRA-1-81 are markers 
that are expressed only in hESCs [10–13].
Recently, several studies have shown that neuronal 
cells [14–16], cardiomyocytes [3], and pancreatic β cells 
[17] can be induced from hESCs. These results give prom-
ise to the clinical application of hESCs for the treatment of 
diseases such as Parkinson’s disease, diabetes, and heart 
disease. However, ESCs can display different differen-
tiation potentials under the same conditions [18–21]. Thus, 
testing the differentiation potentials of existing ESC lines 
is critical in the selection of the appropriate cell line for 
each experimental purpose. For cell replacement therapy 
in the field of neurological disorders, the cell lines that 
most effectively give rise to neuronal populations will be 
useful. Accordingly, establishment and characterization of 
many hESC lines are important in this respect.
Here we report the establishment of new hESC lines, 
SNUhES1, 2, and 3. We observed that these cells have the 
same characteristics as the existing hESC lines in the undif-
ferentiated state and can differentiate into cardiomyocyte lin-
eage in vitro. In addition, our analysis by electron microscopy 
(EM) shows that the undifferentiated hESCs and differenti-
ated cells are clearly different in their cellular structure.
Materials and Methods
Culture from Pronuclear Stage 
Human Embryo to Blastocyst
For derivation of hESC lines, cryopreserved pronuclear 
stage embryos were donated for research purposes, follow-
ing institutional review board approval of Seoul National 
University Hospital and the informed consent of people 
undergoing in vitro fertilization (IVF) treatment. Seventy-
three frozen-thawed pronuclear stage embryos produced 
by IVF were cultured to blastocyst stage in G1.2 and G2.2 
media (Vitrolife AB, Göteborg, Sweden, http://www.vitro-
life.com). Among them, 10 healthy blastocysts that showed 
clear ICM and trophectoderm under the microscope were 
selected for ICM isolation.
Isolation of ICM
ICM was isolated from the blastocysts by either immuno-
surgery [22] or the whole-embryo culture [1] method, as 
described previously. In the isolation of ICM by immuno-
surgery, nine blastocysts containing relatively large ICM 
were first treated with pronase (Sigma Chemical Corp., 
St. Louis, MO, http://www.sigma-aldrich.com) for about 
4–5 minutes to dissolve the zona pellucida. Next, the outer 
trophectoderm layer was removed by the treatment of anti-
human polyvalent immunoglobulins (Sigma) and guinea 
pig complement (Invitrogen, Carlsbad, CA, http://www.
invitrogen.com). Isolated ICM was then plated onto mito-
mycin-C (Sigma)–treated STO (American Type Culture 
Collection [ATCC], Manassas, VA, http://www.atcc.org) 
feeder layers on gelatin-coated tissue culture plates in a 
37°C incubator containing 5% CO2. After 48 hours of plat-
ing, the culture medium was exchanged daily for half of 
the volume. Within 7–8 days of plating, clumps of the cells 
were isolated mechanically and replated on fresh feeder 
layers to derive SNUhES1 and 2.
To isolate ICM without risking cell loss, the whole-
embryo culture method was used for a blastocyst containing 
small ICM, and the blastocyst was cultured on a mitomycin-
C–treated STO feeder layer after digestion of zona pellucida 
with pronase. Within 7–8 days of plating, the central part of the 
cell clump (except the trophoblast) was isolated mechanically 
and subcultured on a fresh feeder layer to derive SNUhES3.
hESC Culture 
hESCs were maintained on STO feeder layers in knock-
out Dulbecco’s modified Eagle’s medium (KO-DMEM) or 
DMEM/F12 (Invitrogen) supplemented with 20% knock-
out serum replacement (Invitrogen), 0.4 ng/ml basic fibro-
blast growth factor (bFGF; Invitrogen), 2 mM L-glutamine 
(Invitrogen), 1% nonessential amino acid (Invitrogen), 
0.1 mM β-mercaptoethanol (Sigma), 50 U/ml penicillin, 
and 50 μg/ml streptomycin (PEST; Invitrogen). The cul-
ture medium was preincubated in a 37°C incubator 1 day 
before usage. The STO (mouse fibroblast) cell line was 
used as a feeder layer for the culture of undifferentiated 
hESCs [12]. The culture medium for expansion of the STO 
cells consisted of DMEM (high glucose with L-glutamine) 
(Invitrogen) supplemented with 10% fetal bovine serum 
(FBS; HyClone, Logan, UT, http://www.hyclone.com), 1 
mM sodium pyruvate (Sigma), 1.5 g/L sodium bicarbonate 
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(Sigma), and PEST (Invitrogen). The expanded STO cells 
were treated with mitomycin-C and frozen. After thawing, 
these cells were seeded on 0.1% gelatin-coated culture dishes 
a day before the hESCs were plated.
Marker Analyses of hESCs
Marker analyses were performed at passages 8 to 10 for 
SNUhES1, passages 6 to 8 for SNUhES2, and passages 12 to 
14 for SNUhES3. Markers were checked every 10 passages 
after that. An alkaline phosphatase (AP) diagnosis kit (Sigma) 
was used to detect AP activity. Briefly, the cells were washed 
with phosphate-buffered solution (PBS) twice, fixed with a 
citrate-acetone-formaldehyde solution for 1 minute, and then 
stained with AP staining solution for 15 minutes in the dark. 
Primary antibodies (Chemicon International, Temecula, CA, 
http://www.chemicon.com) were used at a dilution of 1:100 
for detection of SSEA-1, SSEA-3, and SSEA-4. The primary 
antibodies were localized using biotinylated goat anti-mouse 
immunoglobulin G (IgG) as the secondary antibody, followed 
by treatment of a complex of avidin and horseradish peroxi-
dase (Vectastain ABC system; Vector Laboratories, Burlin-
game, CA, http://www.vectorlabs.com). Finally, a peroxidase 
substrate kit DAB (Vector Laboratories) was used to localize 
the complex. hESC lines were karyotyped at passages 12 to 15 
using the G-band method.
DNA Fingerprinting 
DNA fingerprinting was performed as described previously 
[23]. Briefly, genomic DNA was extracted using the DNeasy 
tissue kit (Qiagen, Valencia, CA, http://www1.qiagen.com). 
DNA fingerprinting was performed on the three cell lines 
using the nine short tandem repeat (STR) loci—FGA, VWA, 
D3S1358, D18S51, D21S11, D8S1179, D7S820, D13S317, 
and D5S818—present in the AmpF/STR Profiler Plus PCR 
amplification kit (Applied Biosystems, Foster, CA, http://
www.appliedbiosystems.com). For polymerase chain reac-
tion (PCR), 2 ng of genomic DNA was amplified for 11 min-
utes at 95°C, followed by 28 cycles of 1 minute at 94°C, 1 
minute at 59°C, 1 minute at 72°C, and a final extension for 
45 minutes at 60°C. Aliquots of 1 μ1 of PCR product were 
mixed with 0.5 μ1 of GeneScan-500 ROX (Applied Bio-
systems) size standard and 2.5 μ1 of deionized formamide. 
The samples were then denatured at 95°C for 2–3 minutes 
and cooled in ice. Electrophoresis was carried out on a 4% 
polyacrylamide sequencing gel on an ABI 377 Genetic Ana-
lyzer (Applied Biosystems) for 2 hours. Fragment sizes were 
determined automatically using Genescan software version 
2.1 and compared with the allelic ladder by Genotyper soft-
ware version 2.1 (both from Applied Biosystems).
Expression Analyses of Oct-4, Cardiomyocyte 
Markers, and Telomerase
To monitor the expression levels of Oct-4 from undifferentiated 
cells and of cardiomyocyte markers from differentiated cells, 
total RNA from the cells was prepared using the RNeasy mini kit 
(Qiagen). cDNA was obtained using 1 μg of RNA with random 
hexamers and avian myeloblastosis virus (AMV) reverse tran-
scriptase (RT; Invitrogen). PCR reactions were carried out with 
5 μ1 of cDNA template, 10 pM of each primer, 8 μ1 of 2.5 mM 
dNTP mix, and 0.1 units of rTaq DNA polymerase (Takara Bio, 
Otsu, Shiga, Japan, http://www.takara-bio.co.jp/english/index.
htm) in a volume of 50 μ1. The following primer sets were used: 
β-actin (forward: 5'-CGCACCCACTGGCATTGTCAT-3')
reverse: 5'-TTCTCCTTGATGTCACGCAC-3')
Oct-4 (forward: 5'-GGCGTTCTCTTTGGAAAGGTGTTC-3') 
reverse: 5'-CTCGAACCACATCCTTCTCT-3')
GAPDH (forward: 5'-AGCCACATCGCTCAGACACC-3') 
reverse: 5'-GTACTCAGCGGCCAGCATCG-3')
GATA4 (forward: 5'-AGACATCGCACTGACTGAGAA-3' )
reverse: 5'-GACGGGTCACTATCTGTGCAAC-3')
Cardiac actin (forward: 5'-TCTATGAGGGCTACGCTTTG-3')
reverse: 5'-CCTGACTGGAAGGTTAGATGG-3')
ANF (forward: 5'-TAGGGACACACTGCAAGAGG-3') 
reverse: 5'-CGAGGAAGTCACCATCAAACCAC-3')
Samples were amplified in a thermocycler under the fol-
lowing conditions for 32 cycles: first, the denaturing step at 
95°C for 40 seconds, then the annealing step at 53°C–60°C for 
40 seconds, and finally the amplification step at 72°C for 40 sec-
onds. PCR products of Oct-4 and cardiomyocyte markers were 
normalized based on the β-actin or GAPDH signals. For detec-
tion of the cardiomyocyte marker cTnI by immunostaining, 
mouse anti-cTnI antibody (1:100; Chemicon) and Alexa Fluor 
488 (green)–labeled donkey anti-mouse IgG (1:200; Molecu-
lar Probes, Eugene, OR, http://www.probes.com) were used as 
primary and secondary antibodies, respectively. Detection of 
telomerase activity was performed using the TRAPEZE Telo-
merase Detection Kit (Chemicon) according to manufacturer’s 
instruction. hESC lines were analyzed at passages 15 to 20. Heat 
inactivation of samples was done at 85°C for 10 minutes. PCR 
products were analyzed on a 12.5% nondenaturing polyacryl-
amide gel and stained with SYBR green I (Sigma).
Teratoma Formation in Severe Combined 
Immunodeficient (SCID) Mice
Approximately 500 hESC colonies at approximately 20 pas-
sages were injected into the rear leg muscles of 4-week-old male 
SCID-beige mice (two mice per cell line). Eight weeks later, the 
resulting teratomas were examined histologically. All three cell 
lines produced teratomas.
214 Derivation and Characterization of hESCs
Transmission Electron Microscopy
hESCs and embryoid bodies (EBs) were collected at different 
stages and fixed with 2.5% glutaraldehyde in 0.1 M phosphate 
buffer (pH 7.4) for 20 minutes at room temperature. After 
being rinsed for 10 minutes in the same buffer, the cells were 
post-fixed with 1% OsO4 in 0.04 M phosphate buffer contain-
ing 0.14 M sucrose for 10 minutes at 4°C. Following dehydra-
tion with ethanol series and infiltration with epoxy resin, cells 
were transferred to beam capsules for polymerization in the 
oven. The capsules were separated from the polymerized resin 
with a razor blade, and embedded cells in hardened blocks 
were viewed with an optical microscope so that the appropri-
ate area was chosen for ultrathin sectioning. Subsequently, 
ultrathin sections were obtained using an ultramicrotome 
(Sorvall MT-6000; DuPont, Wilmington, DE, http://www.
dupont.com) with a diamond knife. Heavy metal staining was 
done with 4% uranyl acetate and lead citrate, and the samples 
were examined through the electron microscope (H-600; Hit-
achi, Tokyo, http://www.hitachi.com) at 50 kv.
In Vitro Differentiation into Cardiomyocytes
Differentiation into cardiomyocytes from hESCs was 
based on the method of Kehat et al. [3] with modifications. 
Briefly, undifferentiated hESC colonies were detached 
by treatment with collagenase IV (Invitrogen) for about 1 
hour at 37°C. EBs were formed from suspension culture 
of hESC colonies in bacterial culture dishes and induced 
into mesodermal fate using DMEM/F12 medium (Invitro-
gen) supplemented with 20% knockout serum replacement 
(Invitrogen) for 1 month. The EBs were next attached onto 
1% gelatin-coated culture dishes and differentiated into 
cardiomyocytes in KO-DMEM (Invitrogen) supplemented 
with 20% FBS (HyClone) for 20 days.
Results
Derivation of Three hESC Lines: SNUhES1, 
SNUhES2, and SNUhES3 
Blastocysts cultured from cryopreserved pronuclear stage 
embryos were used for establishment of hESC lines. Ten 
healthy blastocysts that showed both clear ICM and troph-
ectoderm under the microscope were obtained from 73 
embryos. The ICM was immunosurgically isolated from 
nine blastocysts containing a large ICM [22]. The remaining 
blastocyst had a relatively small ICM, and thus the ICM was 
separated by the whole-embryo culture method [1] to reduce 
the risk of cell loss. ICM isolated by both methods was plated 
onto fresh mouse STO feeder layers. After 5–7 days of culture, 
clumps of small, tightly packed cells proliferated from three 
(two of nine ICM isolated by immunosurgery and one isolated 
by whole-embryo culture) of the 10 ICM. These clumps were 
mechanically dissociated and replated onto fresh feeder lay-
ers. The replated cell clumps after several passages gave rise 
to flat colonies of cells with defined borders that morphologi-
cally resembled human or primate ESCs (Fig. 1A, C, and E). 
Under high magnification (×200), these cells showed a high 
ratio of nucleus to cytoplasm and prominent nucleoli (Fig. 1B, 
D, and F; Fig. 2A), as described previously. Each of SNUhES1, 
2, and 3 cell lines was passaged for more than 90, 120, and 100 
passages, respectively, while maintaining an undifferentiated 
state in the presence of the STO feeder layer. During routine 
passage of the cells, spontaneous differentiation was observed 
in some colonies even in the presence of the STO feeder layer. 
Differentiation usually happened in the central part of the 
colony or in its periphery, and the differentiated portions were 
manually removed before passaging undifferentiated cells.
Marker Expression, Karyotyping and 
DNA Fingerprinting of hESC Lines
Pluripotent hESCs have unique characteristics. In general, 
they show high expression levels of AP, SSEA-3, SSEA-4, 
TRA-1-60, TRA-1-81, Oct-4, and telomerase [10–13]. We 
began to investigate whether our hESC lines fit these criteria. 
As shown in Figure 3A, our cell lines showed a high level of 
AP activity. Elevated expression of this enzyme is associated 
with undifferentiated pluripotent stem cells [10, 11]. Immu-
nophenotyping of the hESCs was performed using a series 
Figure 1. Derivation of human embryonic stem cell lines. Rep-
resentative photographs of (A, B) SNUhES1, (C, D) SNUhES2, 
and (E, F) SNUhES3, respectively, are shown. SNUhES1 and 
2 were derived from nine blastocysts using an immunosurgical 
method, while SNUhES3 was derived from a blastocyst using 
the whole-embryo culture method. Photographs were taken at 
low (×40; A, C, E) or high (×200; B, D, F) magnification.
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Figure 2. Fine structures of undifferentiated and differentiated hESCs. Morphological comparison between (A) undifferentiated and 
(B, C) differentiated hESCs analyzed by electron microscopy. The two types of cells clearly showed a big morphological difference. 
Undifferentiated hESCs have large nuclei with prominent nucleoli, whereas differentiated hESCs exhibit mature cellular organelles. 
Magnification: A, ×3.5K; B, ×8.0K; C, ×12K. Abbreviations: hESC, human embryonic stem cell; RER, rough endoplasmic reticulum.
of antibodies that detect cell surface markers. Our hESCs 
stained positively for SSEA-3, SSEA-4, TRA-1-60, and 
TRA-1-81 (Fig. 3C–F) but not SSEA-1 (Fig. 3B), a marker 
for mESCs. Staining intensity for SSEA-4 was consistently 
strong, but the intensity for SSEA-3 was relatively weak and 
variable among colonies, as reported previously [10]. SSEA-3 
and SSEA-4 are glycoproteins specifically expressed in early 
embryonic development and by undifferentiated hESCs [10, 
11]. TRA-1-60 and -81 are tumor-related antigens that are nor-
mally synthesized by undifferentiated hESCs [10, 11]. In addi-
tion, Oct-4 expression was observed only in undifferentiated 
hESCs, and its expression disappeared when hESCs differen-
tiated (Fig. 4A). Oct-4 is a transcription factor that is essential 
for establishment and maintenance of undifferentiated hESCs 
and mESCs [11, 12, 24]. 
High levels of telomerase activity, a useful marker 
for identifying undifferentiated hESCs [10], were also 
observed in the three cell lines (Fig. 4B). Undifferentiated 
SNUhES1 (lane 4), 2 (lane 6), and 3 (lane 8) showed the 
same high activity as the positive control (lane 1) provided 
by the kit, but heat-inactivated samples (lanes 2, 5, 7, 9, and 
11) and the STO feeder layer (lane 10) did not retain any 
telomerase activity. The high level of telomerase activity in 
these cell lines indicates that they have a potential to infi-
nitely proliferate [10]. Thus, from this pattern of marker 
expression, these cell lines satisfy the criteria that charac-
terize existing, pluripotent hESCs. Karyotyping was per-
formed at passages 12 to 15, and all three cell lines retained 
Figure 3. Marker analyses of hESCs. Staining of ESC mark-
ers such as (A) alkaline phosphatase, (B) SSEA-1, (C) SSEA-
3, (D) SSEA-4, (E) TRA-1-60, and (F) TRA-1-81 are shown 
in SNUhES3 cells (×150 magnification). Similar results were 
obtained for the cell lines SNUhES1 and 2. Abbreviation: 
hESCs, human embryonic stem cells.
216 Derivation and Characterization of hESCs
normal karyotypes (Fig. 5). In this assay, SNUhES1 and 
SNUhES3 had 46,XY karyotypes (Fig. 5A and C), whereas 
SNUhES2 showed a 46,XX karyotype (Fig. 5B). DNA fin-
gerprinting was performed for these cell lines (Table 1). 
From the study of the nine STR loci [25], it is clear that these 
three cell lines were derived from different embryos. These 
fingerprinting results also provide useful information for 
identification of each cell line after cell distribution.
Differentiation Potentials of hESCs in SCID Mice 
An important property of ESCs is their ability to differenti-
ate into all kinds of somatic cell types. To test this potential 
in vivo, the hESCs were injected into SCID mice [10–13]. 
As shown in Figure 6, these cells produced teratomas in 
each injected SCID mouse. Teratomas were found to con-
tain tissues of the three embryonic germ layers: endoderm 
(gut-like structure [Fig. 6A] and gut epithelium [Fig. 6B]), 
mesoderm (cartilage [Fig. 6C]), and ectoderm (neural 
rosettes [Fig. 6D]). When these cell lines were cultured in 
a feeder-free condition, differentiation occurred rapidly in 
vitro (data not shown). When cultured on bacterial Petri 
dishes, these cell lines also showed a potential to make 
EBs, intermediates during the process of differentiation. 
Thus, these results suggest that the established cell lines 
are pluripotent even after prolonged proliferation.
Structural Differences between Undifferentiated 
and Differentiated hESCs
It was reported that undifferentiated hESCs have a high ratio 
of nucleus to cytoplasm [10]. This fact prompted us to investi-
gate the structural differences between undifferentiated and 
differentiated hESCs in more detail using EM. Expanded 
undifferentiated colonies and EBs (8 weeks old) were used for 
analyses by transmission EM (TEM). As expected [10], the 
nucleus to cytoplasm ratio was high in undifferentiated hESCs 
(Fig. 2A). In addition, several other features were observed 
in these cells: They had indistinct cell membranes, free ribo-
somes, and ovoid nuclei with one to three reticulated nucleoli. 
Among the cellular organelles, small mitochondria with a few 
crista, a characteristic of premature cells, were occasionally 
found, but others such as rough endoplasmic reticulum (RER), 
Golgi complex, and lipid droplet were not observed. In con-
trast, differentiated cells showed highly developed cellular 
organelles such as extensive Golgi complexes associated with 
small secretory vesicles and ER studded with ribosomes (Fig. 
2B, C), indicating that cells are actively synthesizing secretory 
Figure 5. Karyotypes of SNUhES cell lines. When analyzed by G-staining method, karyotypes of after 12–15 passages were found to 
be normal: (A) SNUhES1, 46,XY, (B) SNUhES2, 46,XX, and (C) SNUhES3, 46,XY.
Figure 4. Expression of Oct-4 and telomerase in hESC lines. 
(A): Oct-4 expression in hESC lines: lane 1, undifferentiated 
SNUhES1; lane 2, differentiated SNUhES1; lane 3, undiffer-
entiated SNUhES2; lane 4, differentiated SNUhES2; lane 5, 
undifferentiated SNUhES3; lane 6, differentiated SNUhES3; 
lane 7, STO feeder layer. (B): SNUhES cell lines express high 
levels of telomerase activity. A 36-bp internal control was used 
for amplification efficiency and quantification, as indicated by 
the arrow. A ladder of telomerase products amplified by PCR 
is shown with six base increments starting at 50 nucleotides at 
the portion indicated by the asterisk. Lane 1, positive control 
provided by kit; lane 2, heat-inactivated positive control; lane 
3, PCR control without addition of template; lane 4, undiffer-
entiated SNUhES1; lane 5, heat-inactivated SNUhES1; lane 6, 
undifferentiated SNUhES2; lane 7, heat-inactivated SNUhES2; 
lane 8, undifferentiated SNUhES3; lane 9, heat-inactivated 
SNUhES3; lane 10, STO feeder layer; lane 11, heat-inactivated 
STO feeder layer. Abbreviations: hESC, human embryonic 
stem cell; PCR, polymerase chain reaction.
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proteins as in somatic tissues. Organelles like lipid droplet and 
large mitochondria were also evident. Cytoplasmic mem-
branes were irregular and extensively developed to enlarge 
the interface between cells. The existence of desmosomes 
and tonofilaments suggests that these cells differentiated into 
epithelial cells. Microvilli (shown in Fig. 2C) are similar (e.g., 
columnar and dense) to those of gastric epithelial cells. Cyto-
skeleton components such as actin and tonofilaments were 
also shown. Taken together, these results clearly show that 
undifferentiated hESCs have a relatively simple structure dur-
ing proliferation, whereas the differentiated cells resemble 
epithelial cells and display all kinds of cellular organelles 
for intracellular and intercellular activities such as protein 
transport, as shown in adult somatic cells.
In Vitro Differentiation into Cardiomyocytes
To examine the differentiation potentials of three cell lines 
into cardiomyocytes, EBs formed from hESC colonies 
were first induced into mesodermal fate in a suspension 
culture and then differentiated into cardiomyocytes after 
attachment onto culture dishes. In general, mesodermal 
markers (e.g., enolase, cartilage matrix protein) began to be 
expressed approximately 18 days after suspension culture 
of EBs in all three cell lines. Thus, based on the expression 
of mesodermal markers, we attached 20-, 25-, and 30-day-
old EBs onto gelatin-coated culture dishes after suspension 
culture. After further differentiation (~20 days) of attached 
EBs, contracting clusters were found from 30-day-old EBs 
but not from 20- or 25-day-old EBs. Contracting EBs were 
made from SNUhES3 most efficiently (~20% of total clus-
ters), but they were seldom found in SNUhES1 and 2. These 
contractions continued for up to 4 weeks. 
Using immunocytochemistry, the presence of cTnI, a 
cardiac-specific protein that is involved in the regulation 
of cardiac muscle contraction [26], was studied in differ-
entiated EBs. As shown in Figure 7A–C, all three SNUhES 
cell lines expressed cTnI. However, among three cell lines, 
SNUhES1 and 3 showed a relatively strong expression of 
cTnI in comparison with SNUhES2, which revealed a weak 
expression of cTnI. SNUhES1, 2, and 3 cells gave rise to 
about 40%, 19%, and 60%, respectively, in the number of 
cTnI-positive cells among 4,6-diamidino-2-phenylindole–
positive total cells (data not shown). These results indicate 
that of the three cell lines, SNUhES3 differentiates into car-
diomyocytes most effectively. 
Several other cardiac markers were analyzed from the 
SNUhES3 by RT-PCR. Figure 7D shows that GATA4, ANF, and 
cardiac actin (cACT) were also more highly expressed 
in cells differentiated from SNUhES3 (lane 2) than in 
undifferentiated cells (lane 1). GATA4 is known to be 
expressed in precardiac mesoderm of the developing 
heart [27], and ANF is a hormone that is expressed in 
ventricular cardiomyocytes [28].
Discussion
To establish hESC lines, we used 73 cryopreserved 
embryos produced by IVF. These embryos were cultured 
to blastocyst stage for 5–7 days. A blastocyst showing clear 
ICM and trophectoderm under the microscope was judged 
as a healthy blastocyst. In total, 10 healthy blastocysts were 
Figure 6. Teratoma formation after injection of human embry-
onic stem cells into severe combined immunodeficient mice. 
The tissues were stained with hematoxylin and eosin. (A): 
Gut-like structure (endoderm) from SNUhES1. (B): Gut epi-
thelium-like tissue (endoderm) from SNUhES2. (C): Car-
tilage-like tissue (mesoderm) from SNUhES3. (D): Neural 
rosettes-like structure (ectoderm) from SNUhES1.
Table 1. DNA fingerprinting for SNUhES cell lines: distribu-
tion of alleles for the nine short tandem repeat loci in the three 
human embryonic stem cell lines
Allele                         SNUhES1           SNUhES2           SNUhES3
  
D3S1358 17–16 17–16 16–16
  D5S818 11–10 12–11 10–09
  D7S820 11–11 10–08 12–11
  D8S1179 14–10 16–12 15–14
  D13S317 12–10 11–10 10–09
  D18S51 16–14 17–13 13–12
  D21S11 33.3–31 31–30 31.3–31.3
  VWA 18–17 17–17 19–16
  FGA 22–21 23–21 25–23
  Gender XY XX XY
Numbers indicate the genotype of alleles.
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developed from 73 embryos. Among them, nine blastocysts 
showed a relatively large ICM and one contained a small ICM. 
We separated the ICM from nine blastocysts using immuno-
surgery, resulting in the derivation of SNUhES1 and 2 cell 
lines. In contrast, we used whole-embryo culture method for 
the small ICM–containing blastocyst to reduce the risk of 
cell loss. The latter procedure resulted in the establishment of 
SNUhES3 from the blastocyst. Thus, the derivation method 
depended on the size of the ICM in the healthy blastocysts. We 
also obtained seven unhealthy blastocysts from the same 73 
embryos that contained indistinguishable ICM and trophec-
toderm. To isolate ICM from the unhealthy blastocysts, the 
whole-embryo culture method was used, but it was impos-
sible to establish hESC lines after 7-day culture because only 
the trophectoderm was expanded. Therefore, for successful 
establishment of hESC lines, it is important to first get healthy 
blastocysts from embryos, and then a method between immu-
nosurgery and whole-embryo culture should be selected, 
depending on the size of the ICM.
The hESC lines that we derived here are similar in 
properties to those described by several groups [10–13]. 
They showed a similar morphology to already established 
hESCs (Fig. 1) and expressed surface markers of hESCs, 
including SSEA-3, SSEA-4, TRA-1-60, and TRA-1-81 but 
not an mESC marker, SSEA-1 (Fig. 3B–F). These cells also 
expressed high levels of AP activity (Fig. 3A) and Oct-4 
(Fig. 4A) that are markers for both hESCs and mESCs. Oct-
4 is a transcription factor that is limited to pluripotential 
cell populations, and its expression is downregulated dur-
ing differentiation. As shown in Figure 4A, Oct-4 expres-
sion was extinct in a differentiated state. In addition, these 
cell lines showed high levels of telomerase activity (Fig. 
4B), indicating that they can infinitely proliferate. Terato-
mas formed in SCID mice after injection of these hESCs 
included various cell types of the three embryonic germ 
layers (Fig. 6). Also, our hESC lines formed EBs in sus-
pension culture on the bacterial culture dishes and retained 
a potential to differentiate into cardiomyocytes (Fig. 7). 
Taken together, our results suggest that our established 
hESC lines have the same properties as those reported in 
the existing hESC lines and a pluripotency to differentiate 
into all kinds of cells.
Our investigation using EM provides useful informa-
tion regarding structural differences between undifferen-
tiated and differentiated ESCs (Fig. 2). There have been 
reports that ESCs have a high ratio of nucleus to cytoplasm 
[10, 12]. Our EM analysis clearly shows unique character-
istics in the undifferentiated hESCs compared with dif-
ferentiated cells. Undifferentiated hESCs had large nuclei 
containing reticulated nucleoli, indistinct cell mem-
branes, free ribosomes, and small mitochondria with a few 
crista, but not any other cellular organelles (Fig. 2A). In 
contrast, differentiated cells displayed highly developed 
cellular organelles such as Golgi complex, ER with ribo-
somes, lipid droplets, and large mitochondria (Fig. 2B, C). 
Observation of desmosomes and tonofilaments indicates 
that these cells differentiated into epithelial cells. The 
microvilli shown in Figure 2C are columnar and dense, 
suggesting that these cells differentiated into gastric epi-
thelial cells. From these results, we can clearly see that 
undifferentiated ESCs have a unique, premature structure, 
whereas differentiated cells developed cellular machinery 
for various cellular activities, including protein secretion. 
The DNA fingerprinting for each cell line performed in 
this research provides information for cell line identity 
that could prove to be crucial in determining if contamina-
tion between cell lines occurred (Table 1).
From our observations and the reports from other groups 
[18–21], it is clear that all ESCs are different from each other 
in terms of differentiation potentials although they share 
characteristics in the undifferentiated state. For instance, 
Figure 7. Analyses of embryonic stem cell–derived cardio-
myocytes by immunostaining and reverse transcription poly-
merase chain reaction. (A–C): Immunostaining of differen-
tiated EBs with mouse anti-cTnI antibody and Alexa Fluor 
488 (green)–labeled donkey anti-mouse immunoglobulin G 
on SNUhES1, 2, and 3, respectively. (D): Expression of car-
diac-specific markers in EBs (lane 2) differentiated from 
SNUhES3 compared with undifferentiated SNUhES3 (lane 
1). Abbreviation: EB, embryoid body.
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certain ESCs have a better ability than others in specific 
differentiation into neuronal phenotypes. Accordingly, the 
derivation of many hESCs and studies on them will provide 
more insights into the clinical application of hESCs. Further 
analysis of our cell lines in differentiation into other pheno-
types will provide valuable information for application to 
cell replacement therapy.
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